Multi-cancer early detection tests for cancer screening: a behavioural science perspective

Marlow, Laura A. V., Schmeising-Barnes, Ninian, Brain, Kate ORCID: https://orcid.org/0000-0001-9296-9748, Duncombe, Sue, Robb, Kathryn A., Round, Thomas, Sanderson, Saskia C. and Waller, Jo 2022. Multi-cancer early detection tests for cancer screening: a behavioural science perspective. The Lancet Oncology 23 (7) , pp. 837-839. 10.1016/s1470-2045(22)00161-9

Preview

PDF - Accepted Post-Print Version Download (551kB) | Preview

Abstract

Identifying circulating cell-free tumour DNA in blood offers the potential for multi-cancer early detection (MCED) tests. Several trials assessing the effect of MCED tests on early asymptomatic cancer detection are underway (eg, ISRCTN91431511 and NCT04213326). MCED tests differ substantially from existing cancer screening tests (appendix p 1). If MCED tests are shown to improve cancer outcomes, careful consideration of other potential benefits and harms will be essential before these are made available to the general population. 1 Many of these are psychological or behavioural, making theory-driven behavioural research indispensable to their successful implementation.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Elsevier
ISSN:	1470-2045
Date of First Compliant Deposit:	22 March 2022
Date of Acceptance:	15 March 2022
Last Modified:	19 Nov 2024 09:15
URI:	https://orca.cardiff.ac.uk/id/eprint/148577

Actions (repository staff only)

Edit Item